Noble metal nanoparticles have been sought after in cancer nanomedicine during the past
two decades, owing to the unique localized surface plasmon resonance that induces strong …

Hypoxia, or low oxygen levels, is a common feature of the tumor microenvironment. It is
caused by the aggressive proliferation of cancer cells, which consume more oxygen than …

Designing nanozyme hybrids with cascade catalytic activities and coupling effects has
significant promises in tumor therapy through concerted effects. In this work, a goethite …

Compared to conventional photothermal therapy (PTT) which requires hyperthermia higher
than 50° C, mild‐temperature PTT is a more promising antitumor strategy with much lower …

Although mild photothermal therapy (mild-PTT) avoids treatment bottleneck of the traditional
PTT, the application of mild-PTT in deep and internal tumors is severely restricted due to …

With the booming development of nanomedicine, mild photothermal therapy (mPTT, 42–45°
C) has exhibited promising potential in tumor therapy. Compared with traditional PTT (> 50° …

Despite the clinical success of immune checkpoint blockade (ICB) therapies, overcoming
immunologically “cold” tumors remains challenging. Photothermal therapy (PTT) has been …

Oxygen as one of the most critical substances in living organisms has attracted ever‐
increasing attention in disease treatment, which is important in regulating metabolic …

Mild photothermal therapy (mPTT), which circumvents the limitations of conventional
photothermal therapy, is emerging and exhibits remarkable potential in clinical applications …

Simple Summary Photothermal therapy (PTT) has become effective through the
development of nanoparticle-based photoabsorbers with various functions, such as …